Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)

Funder: National Institutes of Health

Due Dates: June 13, 2025 (Full Application) | May 14, 2025 (Letter of Intent recommended)

Funding Amounts: Up to $900,000 direct costs/year (excluding IOF); IOF up to $350,000 direct costs/year; 5-year project period; 4–5 awards expected; total NIAID commitment: $6.08M/year.

Summary: Supports multidisciplinary research centers to advance understanding and treatment of asthma and allergic diseases through integrated clinical and translational studies.

Key Information: Limited submission: only one application per institution; clinical trial optional; majority of research must involve human subjects or human materials.


Sign in to see full grant listing

Atom | Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)